Product How it works Pricing Blog FAQ About Contact
Ocular Therapeutix

Ocular Therapeutix (NASDAQ: OCUL) revenue

Ocular Therapeutix reported revenue of $52.0m for fiscal 2025, 18.5% less than in fiscal 2024 ($63.7m). Since fiscal 2016 its revenue has grown by 2,653.1%, an average growth of 44.5% a year.

Ocular Therapeutix's best year of the last 10 was fiscal 2024. The biggest drop was in fiscal 2025, −18.5%.

Revenue, in millions of US dollars1.920161.920172.020184.2201917.4202043.5202151.5202258.4202363.7202452.02025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$52.0m−18.5%−$270.0m−519.8%
2024$63.7m+9.0%−$171.8m−269.6%
2023$58.4m+13.5%−$82.4m−141.0%
2022$51.5m+18.3%−$78.7m−152.7%
2021$43.5m+150.1%−$78.0m−179.3%
2020$17.4m+311.7%−$62.8m−361.1%
2019$4.2m+112.4%−$85.8m−2,029.9%
2018$2.0m+3.5%−$59.1m−2,970.8%
2017$1.9m+1.9%−$61.9m−3,220.1%
2016$1.9m—−$43.3m−2,296.0%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Ocular Therapeutix revenue compared with its sector

By revenue for its latest fiscal year, Ocular Therapeutix ranks 327th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Ocular Therapeutix, −18.5%.

RankCompanyRevenueRevenue growth
325thInvivyd$53.4m110.5%
326thProtalix Biotherapeutics$52.7m−1.2%
327thOcular Therapeutix$52.0m−18.5%
328thLexicon Pharmaceuticals$49.8m60.2%
329thProtagonist Therapeutics$46.0m−89.4%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Ocular Therapeutix

How much revenue did Ocular Therapeutix make in fiscal 2025?
Ocular Therapeutix reported revenue of $52.0m for fiscal 2025, compared with $63.7m in fiscal 2024.
How much has the revenue of Ocular Therapeutix grown?
Between fiscal 2016 and fiscal 2025 it went from $1.9m to $52.0m: 2,653.1% more, an average growth of 44.5% a year.
What was the best year for revenue at Ocular Therapeutix?
Of its last 10 fiscal years, fiscal 2024, with $63.7m.
Where does Ocular Therapeutix rank in its sector by revenue?
It ranks 327th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Ocular Therapeutix come from?
From the annual report (Form 10-K) that Ocular Therapeutix files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Ocular Therapeutix files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Ocular Therapeutix: the Ocular Therapeutix page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.